A global bibliometric and visual analysis of research on premature ovarian failure: Based on the perspective of stem cells

Author:

Xu Zhiguo123,Zhu Yi45ORCID,Liu Lefeng23,Liu Chao3,Dong Zhilong67

Affiliation:

1. Department of Pharmaceutical Engineering, School of Life and Health Sciences, Huzhou College, Huzhou, Zhejiang Province, China

2. School of Life Sciences and Technology, Tongji University, Shanghai, China

3. Xiehe Union East China Stem Cell & Gene Engineering Co., Ltd, Huzhou, Zhejiang Province, China

4. Shaoxing University Yuanpei College, Shaoxing, Zhejiang Province, China

5. Huzhou University, Huzhou, Zhejiang Province, China

6. Tianjin Cord Blood Bank, National Industrial Base for Stem Cell Engineering Products, Tianjin, China

7. State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences and College of Life Sciences, Nankai University, Tianjin, China.

Abstract

Premature ovarian failure (POF), a condition influenced by genetic and immune factors, remains incurable despite years of intensive research and significant efforts. This persisting challenge underscores the urgency to address this escalating health concern. Fortunately, stem cell regenerative medicine has emerged as a promising avenue for developing therapeutic strategies and innovative treatments for POF. Bibliometric analysis, renowned for its objectivity, systematic approach, and comprehensive coverage of a given field, has yet to be applied to the study of stem cell research in POF. This study used CiteSpace software to assess contributions and co-occurrence relationships among various countries/regions, institutes, journals, and authors. This approach also allowed us to identify research hotspots and promising future trends within this field. Additionally, we generated visualizing maps utilizing the Web of Science Core Collection (WOSCC) and PubMed publications. By providing valuable information and references, we aim to enhance the understanding of the challenges involved in translating stem cell regeneration into clinical therapeutic potential for POF. Furthermore, our analysis and findings guide researchers and clinicians, facilitating future collaborative research and clinical intervention efforts.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference42 articles.

1. Premature ovarian failure.;Shelling;Reproduction,2010

2. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.;Pastore;J Assist Reprod Genet,2018

3. Premature ovarian failure.;Jankowska;Prz Menopauzalny,2017

4. Niacin inhibits apoptosis and rescues premature ovarian failure.;Wang;Cell Physiol Biochem,2018

5. Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge.;Szeliga;Int J Mol Sci,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3